Learn About Chordoma

View Main Condition: Brain Tumor

What is the definition of Chordoma?

A chordoma is a rare type of cancerous tumor that can occur anywhere along the spine, from the base of the skull to the tailbone. Chordomas grow slowly, gradually extending into the bone and soft tissue around them. They often recur after treatment, and in about 40 percent of cases the cancer spreads (metastasizes) to other areas of the body, such as the lungs.

What are the causes of Chordoma?

Changes in the TBXT gene have been associated with chordoma. An inherited duplication of the TBXT gene identified in a few families is associated with an increased risk of developing a chordoma. Duplications or increases in activity (expression) of the TBXT gene have also been identified in people with chordoma who have no history of the disorder in their family. In these individuals, the changes occur only in the tumor cells and are not inherited.

How prevalent is Chordoma?

Chordomas are rare, occurring in approximately 1 per million individuals each year. Chordomas comprise fewer than 1 percent of tumors affecting the brain and spinal cord.

Is Chordoma an inherited disorder?

When development of a chordoma is associated with a duplication of the TBXT gene inherited from a parent, one copy of the altered gene in each cell is sufficient to increase the risk of the disorder, which is an inheritance pattern called autosomal dominant. People with this duplication inherit an increased risk of this condition, not the condition itself.

Who are the top Chordoma Local Doctors?
Neurosurgery
Neurosurgery

Shawnee Mission Medical Center Inc

9100 W 74th St, Ahmg Cardiology At Shawnee Mission, 
Merriam, KS 
 (93.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jayson Neil is a Neurosurgery provider in Merriam, Kansas. Dr. Neil and is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Spinal Stenosis, Brain Aneurysm, Hemangioblastoma, Herniated Disc Surgery, and Cervical Disc Surgery. Dr. Neil is currently accepting new patients.

Hematology Oncology | Hospital Medicine | Hematology
Hematology Oncology | Hospital Medicine | Hematology

Midwest Oncology Associates LLC

5721 W 119th St, Menorah Medical Center, 
Overland Park, KS 
 (98.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Joseph Stilwill is a Hematologist Oncology specialist and a Hospital Medicine provider in Overland Park, Kansas. Dr. Stilwill and is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Mantle Cell Lymphoma (MCL), Familial Colorectal Cancer, Lung Cancer, and Colorectal Cancer. Dr. Stilwill is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Family Medicine
Family Medicine

Community Healthcare System Inc

114 W 8th St, 
Onaga, KS 
 (24.1 mi)
Experience:
23+ years
Languages Spoken:
English
Accepting New Patients

Rebecca Simon is a Family Medicine provider in Onaga, Kansas. Dr. Simon has been practicing medicine for over 23 years and is rated as an Experienced provider by MediFind in the treatment of Chordoma. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Shingles. Dr. Simon is currently accepting new patients.

What are the latest Chordoma Clinical Trials?
A Phase 1/2 Study of Tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients With Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Summary: This phase I/II trial studies how well tiragolumab and atezolizumab works when given to children and adults with SMARCB1 or SMARCA4 deficient tumors that have either come back (relapsed) or do not respond to therapy (refractory). SMARCB1 or SMARCA4 deficiency means that tumor cells are missing the SMARCB1 and SMARCA4 genes, seen with some aggressive cancers that are typically hard to treat. Immuno...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The TNT Protocol: A Phase 2 Study Using Talimogene Laherparepvec,Nivolumab and Trabectedin as First, Second/Third Line Therapy for Advanced Sarcoma, Including Desmoid Tumor and Chordoma

Summary: This is a Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin as first, second or third line therapy for advanced sarcoma, including desmoid tumor and chordoma.

Who are the sources who wrote this article ?

Published Date: May 01, 2015
Published By: National Institutes of Health